Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PREVISCAN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 13 adverse event reports in the FDA FAERS database where PREVISCAN was used for Atrial fibrillation.

Most Reported Side Effects for PREVISCAN

Side Effect Reports % Deaths Hosp.
International normalised ratio increased 19 16.7% 4 13
Anaemia 13 11.4% 0 11
Haematoma 11 9.7% 1 9
Metastasis 10 8.8% 0 0
Renal failure acute 9 7.9% 1 9
Shock haemorrhagic 8 7.0% 1 1
Subdural haematoma 8 7.0% 8 3
Bradycardia 7 6.1% 1 7
Epistaxis 6 5.3% 0 6
Hepatocellular injury 6 5.3% 1 6
Hyperkalaemia 6 5.3% 2 6
Renal failure 6 5.3% 1 5
Asthenia 5 4.4% 0 5
Dehydration 5 4.4% 0 5
Diarrhoea 5 4.4% 0 5

Other Indications for PREVISCAN

Product used for unknown indication (25) Thrombosis prophylaxis (13) Deep vein thrombosis (5)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

PREVISCAN Full Profile All Atrial fibrillation Drugs PREVISCAN Demographics PREVISCAN Timeline